Global Diabetes Drug Market will be US$ 78.10 Billion by 2026

1
Global Diabetes Drug Market
Global Diabetes Drug Market
2
Report Description and Highlights
According to the latest report by Renub Research,
titled "Diabetes Drug Market Global Forecast By
Disease, Oral Therapy, Injection, Insulin,
Regions, Company" Diabetes drugs are used to
treat pre-diabetes and diabetes mellitus type 2
by controlling the blood glucose level of the
body. There are different classes of medicine for
the treatment of this diabetes, which are given
to patients through oral, intravenous, and
subcutaneous routes. According to Renub Research
analysis, Global Diabetes Drug Market is
forecasted to be US 78.10 Billion by 2026. This
growth is due to the rising number of diabetes
patients worldwide, increasing per capita income.
Another reason is with the use of machines
people are following a sedentary lifestyle, which
leads to obesity, a decline of physical activity,
and consumption of unhealthy meals. Besides,
growth in the aging population is also one of the
other reasons
Global Diabetes Drug Market
3
Global Diabetes Drug Market
According to WHO stats, the number of diabetes
patients has risen to 422 Million in the year
2014 from 108 Million in the year 1980. The
prevalence of diabetes patients for adults aging
more than 18 years was 4.7 percent in the year
1980, which has risen to 8.5 percent in the year
2014. Initially, diabetes was limited to only a
small region of the world now, it has been
growing in middle and low-income countries at a
faster pace. This disease leads to several
life-threatening diseases such as heart attacks,
stroke, kidney failure, blindness, and lower limb
amputation. This disease was the reason for 1.6
Million deaths in the year 2016. Diabetes was the
7th leading reason for death in the year
2016. To avoid this disease, WHO has given
prevention through which an individual can live a
healthy life, such as to prevent or delay type 2
diabetes people should have and manage a healthy
BMI (Body Mass Index) ratio. Physical exercise of
at least 30 minutes of regular and
moderate-intensity activity should be done daily
for weight control. Diet should be healthy
without saturated fat and sugar. The use of
tobacco should be avoided, as smoking is liable
for the risk of diabetes, heart ailments, and
respiratory disorders.
Global Diabetes Drug Market
4
Global Diabetes Drug Market
COVID-19 impact on Diabetes Drug Market Most of
the countries are affected by the COVID-19
pandemic, the healthcare system and economic
activities are disturbed by lockdown imposed by
governments. Currently, the treatment of COVID-19
is the priority of healthcare department, and
hospitals have stopped treatment of other
diseases as beds are reserved for COVID-19
patients. Diabetes patients have to depend on
medicines prescribed by doctors, and governments
are investing heavily in their healthcare
systems. This will also help in research and
development of diabetes drugs which is propelled
by massive investment in the pharma industry.
Request a free sample copy of the report
https//www.renub.com/request-sample-page.php?gtur
ldiabetes-drug-market-p.php
Global Diabetes Drug Market
5
Global Diabetes Drug Market
The global diabetes drug market will grow in the
future due to the increasing adoption of diabetes
drugs in the following nations such as the United
Kingdom, China, Germany, India, France, Japan,
and Spain. Most of the small and big market
players are launching new diabetes drugs at
regular intervals besides, this collaboration,
partnership, expansion, and acquisition between
them will also propel the global diabetes drugs
market. There are numerous diabetes drugs used
to treat type 2 diabetes, such as Lantus
subcutaneous, Metformin, Avandia, Invokana, and
Actos. All drugs are given orally expect insulin,
Pramlintide, Exenatide, and Liraglutide. Insulin
is injected through delivery devices, including
insulin syringe, intravenous sets, jet injectors,
infusion pump, and insulin pen.
Global Diabetes Drug Market
6
Global Diabetes Drug Market
Market Summary By Disease This research report
has covered the market of Type 1, Type 2
diabetes, according to Renub Research
analysis. Oral Therapy The market for following
Oral Therapies is covered in this report, such as
Biguanide, SGLT-2, Alpha Glucosidase Inhibitor,
(DPP) IV Inhibitor, and Others Oral Drug. By
Injection This report gives the market for
following injection Glucagon-like peptide (GLP) 1
agonist, Amylin receptor against By Insulin The
market for following insulin types are covered in
the research report Rapid Acting Insulin, Long
Acting Insulin, Premixed Insulin, and Other
Insulin.
Request a free Brochure copy of the report
 https//www.renub.com/request-brochure-page.php?g
turldiabetes-drug-market-p.php
Global Diabetes Drug Market
7
Global Diabetes Drug Market
By Insulin The market for following insulin
types are covered in the research report Rapid
Acting Insulin, Long Acting Insulin, Premixed
Insulin, and Other Insulin. By Regions The
following regions are covered in the research
report Japan, India, United States, 5European
Union, Canada, China, and Brazil. By
Company Overview, RD Pipeline and Sales
Analysis of Novo Nordisk, Merck Co, Eli Lilly,
AstraZeneca, Johnson Johnson are given in the
research report.
Global Diabetes Drug Market
8
Global Diabetes Drug Market
Browse Related Report CAR T Cell Therapy
Market Hepatitis C Drugs Market Contact Us Tel
1-678-302-0700 (US), 91-120-421-9822
(INDIA) Email info_at_renub.com
Global Diabetes Drug Market